Fourth Quarter and Full Year 2022 Financial Results Conference Call
March 16, 2023 at 4:30pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID # 13736281.
There are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases.
March 16, 2023 at 4:30pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID # 13736281.
November 14, 2022 at 4:30 pm ET
To access the live conference call, please dial 855-327-6837 from the U.S. and Canada, or 631-891-4304 internationally, Conference ID #10020554.
August 11, 2022 at 4:30pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID#13730902.
June 22 - June 25, 2022
London, UK
June 23rd 9:00 – 18:30 BST
1529:
1“Seladelpar Treatment of Patients With Primary Biliary Cholangitis (PBC) For 2 Years Improves the GLOBE PBC Score and Predicts Improved Transplant-Free Survival”
Bettina E. Hansen, Elaine Watkins, Ke Yang, Yun-Jung Choi, Charles A. McWherter, Gideon M. Hirschfield, for the Seladelpar Long-Term Study Investigators
June 24th 9:00 – 18:00 BST
1518:
2“Comparative fibrosis-reducing activities of farnesoid X receptor (FXR), peroxisome-proliferator activated receptor delta (PPAR) and thyroid hormone receptor (THR) agonists in the carbon tetrachloride mouse model”
Edward Cable, Jeffrey Stebbins, Yun-Jung Choi, Jiangao Song, Prasad Manchem, Sanjay Pandey, Charles A. McWherter
Oral Presentation:
June 25th 9:00 AM BST
2726:
3“The selective PPAR-delta agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 through the FGF21 pathway”
Tetsuya Kouno, Xiao Liu, Tatiana Kisseleva, Edward E. Cable, Bernd Schnabl
Congress attendees can visit CymaBay throughout the meeting at booth 93.
A full list of presentations can be found on The International Liver Congress ™ 2022 website.
May 22, 2022
May 22nd 8:00 AM PDT
323:
1“Seladelpar Treatment of Patients With Primary Biliary Cholangitis (PBC) For 2 Years Improves the GLOBE PBC Score and Predicts Improved Transplant-Free Survival”
Bettina E. Hansen, Elaine Watkins, Ke Yang, Yun-Jung Choi, Charles A. McWherter, Gideon M. Hirschfield,
for the Seladelpar Long-Term Study Investigators
Clinical Poster Presentations:
May 22nd 12:30 PM PDT
1348:
2“Efficacy, Safety, and Tolerability of Seladelpar in Patients With Compensated Liver Cirrhosis Due to Primary Biliary Cholangitis (PBC): A Pooled Analysis of Phase 2 and Phase 3 Studies”
Stuart C Gordon, Palak Trivedi, Christopher Bowlus, Michael R Galambos, Aparna Goel, Aliya Gulamhusein, Cynthia Levy, Guy Neff, Carmen Stanca, Douglas Thorburn, Bruce Bacon, Brian Borg, Yvonne Döerffel, Lisa Forman, Bradley Freilich, Liana Gheorghe, María Saraí González-Huezo, Stephen Harrison, Jonathan Huang, Sook-Hyang Jeong, Seung Up Kim, John Lake, Joseph Odin, Won Young Tak, Hillel Tobias, John M. Vierling, Ke Yang, Alexandra (Sasha) Steinberg, Yun-Jung Choi, Charles McWherter, Marlyn J. Mayo
May 22nd 12:30 PM PDT
1351:
3“Treatment With Seladelpar in Patients With Primary Biliary Cholangitis (PBC) and Prior Experience With Obeticholic Acid (OCA) or Fibrates”
Aliya Gulamhusein, Guy Neff, Aparna Goel, Marlyn J. Mayo, Carmen Stanca, Christopher Bowlus, Lisa Forman, Pietro Invernizzi, Frederik Nevens, Ehud Zigmond, Eli Zuckerman, Ke Yang, Yun-Jung Choi, Alexandra (Sasha) Steinberg, Charles McWherter, Kris V. Kowdley
A full list of presentations can be found on https://ddw.org/.
May 12, 2022 at 4:30pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID#13728967.
March 17, 2022 at 4:30pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13726915.
November 15, 2021 at 4:30pm ET
November 12 - November 15, 2021
Virtual
Oral Presentation: November 14th 1:00 PM EST
106: “Long-Term Safety and Efficacy of Seladelpar in Patients with Primary Biliary Cholangitis”
Clinical Poster Presentation: November 12th – 15th
1269: “Efficacy and Safety of Seladelpar in Patients with Compensated Cirrhosis and Evidence of Portal Hypertension due to Primary Biliary Cholangitis”
Preclinical Poster Presentation: November 12th – 15th
1334: “Seladelpar reduces established Liver and Renal Fibrosis in the Non-obese Diabetic Inflammation and Fibrosis (NIF) Mouse Model”
November 10, 2021 at 4:30pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13723498.
September 13, 2021 at 7:00AM ET
September 9, 2021
Virtual Meeting
1-on-1 meetings only.
August 12, 2021 at 4:30pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13720877.
June 28, 2021 at 3:00 pm ET
Please use the access code below to view the Webinar replay.
Access Code: Piper123!
June 23 - June 26, 2021
June 21, 2021 at 9:20 am ET
June 17, 2021
June 10, 2021 at 8:00 AM PT
Virtual Meeting
Meeting Link: https://www.virtualshareholdermeeting.com/CBAY2021May 13, 2021 at 4:30pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13718350.
March 25, 2021 at 4:30 pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13715944.
March 12, 2021 at 5:00 pm MT
February 25, 2021 at 12:00 pm ET
Track V
November 13 - November 16, 2020
September 9, 2020
1-on-1 meetings only
August 27 - August 29, 2020
Virtual
August 10, 2020 at 4:30 pm ET
To access the live conference call, please dial 877-407-0784 from the U.S. and Canada, or 201-689-8560 internationally, Conference ID# 13706143.
June 23, 2020 at 10:00 am PT
Virtual Meeting
Meeting Link: www.virtualshareholdermeeting.com/CBAY2020